dactinomycin and alpha 1-Antitrypsin Deficiency

dactinomycin has been researched along with alpha 1-Antitrypsin Deficiency in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horn, M; Ruchelli, ED; Taylor, SR	1

Other Studies

1 other study(ies) available for dactinomycin and alpha 1-Antitrypsin Deficiency

Article	Year
Severe chemotherapy-related hepatic toxicity associated with MZ protease inhibitor phenotype. The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3 Topics: Alleles; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dactinomycin; Disease Susceptibility; Hemorrhage; Heterozygote; Humans; Infant; Kidney Neoplasms; Liver Diseases; Liver Transplantation; Male; Necrosis; Phenotype; Vincristine; Wilms Tumor	1990

Article

Year

Severe chemotherapy-related hepatic toxicity associated with MZ protease inhibitor phenotype.

The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

Topics: Alleles; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dactinomycin; Disease Susceptibility; Hemorrhage; Heterozygote; Humans; Infant; Kidney Neoplasms; Liver Diseases; Liver Transplantation; Male; Necrosis; Phenotype; Vincristine; Wilms Tumor

1990